PropertyValue
?:abstract
  • In an attempt to complement the syndromic picture of the coronavirus disease (COVID-19), a wide range of neurologic, gastrointestinal, dermatologic and even oral symptoms adjacent to the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection has been recently reported. While consensus about the non-respiratory symptoms is strongly advocated through rigorous reporting guidelines, this series gives an account of transient snoring symptoms experienced by laboratory-confirmed COVID-19 patients; and for better communication, this complication will be referred to as (CVTS). The clinical and laboratory findings of nine consecutive patients with CVTS have been reported according to the CARE guidelines. In conclusion, this series is the first evidence on non-apnea snoring cases infected by SARS-COV-2. However, the cause and pathophysiologic course remain unclear, further similar cases of CVTS should be reported in order to better understand this novel complication. This article is protected by copyright. All rights reserved.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1002/jmv.26705
?:journal
  • J_Med_Virol
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/cd520e1334d78d9b228f6d51265bbc5964d26e3d.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7753588.xml.json
?:pmcid
?:pmid
?:pmid
  • 33289127.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • COVID‐19 transient snoring (CVTS): Clinical and laboratory description
?:type
?:year
  • 2020-12-17

Metadata

Anon_0  
expand all